Parkman Healthcare Partners’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.38M | Buy |
128,478
+23,478
| +22% | +$1.53M | 0.96% | 36 |
|
|
2025
Q1 | $7.03M | Buy |
+105,000
| New | +$7.03M | 0.83% | 42 |
|
|
2023
Q4 | – | Sell |
-111,802
| Closed | -$6.49M | – | 92 |
|
|
2023
Q3 | $6.49M | Sell |
111,802
-62,675
| -36% | -$3.64M | 1.19% | 29 |
|
|
2023
Q2 | $9.39M | Buy |
174,477
+74,477
| +74% | +$4.01M | 1.63% | 21 |
|
|
2023
Q1 | $3.97M | Sell |
100,000
-26,874
| -21% | -$1.07M | 0.86% | 41 |
|
|
2022
Q4 | $5.1M | Buy |
126,874
+8,933
| +8% | +$359K | 1.36% | 26 |
|
|
2022
Q3 | $3.79M | Buy |
117,941
+9,382
| +9% | +$302K | 1.08% | 31 |
|
|
2022
Q2 | $3.22M | Buy |
108,559
+648
| +0.6% | +$19.2K | 1.19% | 27 |
|
|
2022
Q1 | $3.03M | Sell |
107,911
-29,315
| -21% | -$824K | 0.89% | 39 |
|
|
2021
Q4 | $6.32M | Buy |
137,226
+51,880
| +61% | +$2.39M | 1.4% | 26 |
|
|
2021
Q3 | $2.8M | Buy |
85,346
+30,000
| +54% | +$985K | 0.71% | 44 |
|
|
2021
Q2 | $1.94M | Buy |
+55,346
| New | +$1.94M | 0.42% | 60 |
|